First Numinus Network™ partner enters into agreement Recent cost containment initiatives have resulted in approximately $4.2 million of annualized savings, extending cash runway Well positioned to provide psychedelic-assisted therapy insurance reimbursement, as a result of recent US insurance payor code approval MDMA-assisted therapy expected to be approved for treatment in US in 2024 – Numinus […]
- May 2023
- LONDON, May 25, 2023 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today announces an update to its intellectual property (“IP“) portfolio, demonstrating significant progress already made by the Company in 2023. Small Pharma aims to […]
Preliminary data on the public health and safety impacts of personal possession legalization of psychedelics in Colorado
The post Report: Legal Psychedelics In Colorado Have Not Increased Public Health Harms appeared first on Microdose.
The California Senate has passed a bill legalizing the possession of natural psychedelics.
The post Bill To Legalize Psychedelics Passes California Senate appeared first on Microdose.
Cybin announced the first participants have been dosed with CYB004 in its three-part Phase 1 clinical trial
The post Cybin Initiates First-in-Human Dosing of CYB004 in Phase 1 Clinical Trial appeared first on Microdose.
- No more posts to load